Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Drug Substance

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Addressing the Evolving Nitrosamine Contamination Issue

Nitrosamine Impurities

Addressing the Evolving Nitrosamine Contamination Issue

Olon

PAO-09-23-CL-07September 15, 2023

Streamlining Process Validation for Drug Substance Manufacturing

Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

Gerhard Noessner, Ph.D.; Juergen Utz, Ph.D.; Juergen Bank, Ph.D.

Fareva

PAO-02-022-CL-19March 15, 2022

New Method Developed for Stereoselective Synthesis of Biologic Drug Substances

Biologics

New Method Developed for Stereoselective Synthesis of Biologic Drug Substances

Emilie Branch

Pharma's Almanac

PAO-M08-18-NI-011August 08, 2018

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

Drug Development

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

Amorsa Therapeutics

PR-M01-18-NI-029January 11, 2018

China FDA Publishes Guidance for Priority Review

CFDA

China FDA Publishes Guidance for Priority Review

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M01-18-NI-013January 09, 2018

Pfizer Receives FDA Approval for Remicade® Biosimilar

Biosimilars

Pfizer Receives FDA Approval for Remicade® Biosimilar

Nice Insight

PAO-M12-17-NI-039December 28, 2017

Needle-Free Injection Technology Advances to Phase II Trial

Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

Nice Insight

PAO-M12-17-NI-035December 26, 2017

Transporters Targeting Cell’s Metabolic Gates Win Financing

Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

Nice Insight

PAO-M12-17-NI-037December 26, 2017

Needle-Free Injection Technology Advances to Phase II Trial

Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

Nice Insight

PAO-M12-17-NI-035-4949December 26, 2017

NDA Submitted for Antimalarial Drug

FDA

NDA Submitted for Antimalarial Drug

Nice Insight

PAO-M12-17-NI-034December 26, 2017

Tumor Killing Combo Wins Third U.S. Patent

Research

Tumor Killing Combo Wins Third U.S. Patent

Nice Insight

PAO-M12-17-NI-033December 21, 2017

Chinese Biopharma Receives Series A Financing

Drug Development

Chinese Biopharma Receives Series A Financing

Nice Insight

PAO-M12-17-NI-031December 21, 2017

BioVectra and Keryx Expand Strategic API Supply Relationship

Strategic Partnership

BioVectra and Keryx Expand Strategic API Supply Relationship

Nice Insight

PAO-M12-17-NI-030December 21, 2017

First “Follow-On” Insulin Product Approved

Diabetes

First “Follow-On” Insulin Product Approved

Nice Insight

PAO-M12-17-NI-019December 14, 2017

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

3D Printing

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

Nice Insight

PAO-M12-17-NI-018December 14, 2017